ChemicalBook >> CAS DataBase List >>3-[(1S,2S)-1-[2-[[(4S)-3-(2,3-Dihydro-2-oxo-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-1H-indol-1-yl]-2-methylcyclopropyl]-1,2,4-oxadiazol-5(2H)-one

3-[(1S,2S)-1-[2-[[(4S)-3-(2,3-Dihydro-2-oxo-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-1H-indol-1-yl]-2-methylcyclopropyl]-1,2,4-oxadiazol-5(2H)-one

CAS No.
2212020-29-4
Chemical Name:
3-[(1S,2S)-1-[2-[[(4S)-3-(2,3-Dihydro-2-oxo-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-1H-indol-1-yl]-2-methylcyclopropyl]-1,2,4-oxadiazol-5(2H)-one
Synonyms
Orforglipron Impurity 60;3-[(1S,2S)-1-[2-[[(4S)-3-(2,3-Dihydro-2-oxo-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-1H-indol-1-yl]-2-methylcyclopropyl]-1,2,4-oxadiazol-5(2H)-one
CBNumber:
CB013571599
Molecular Formula:
C40H43FN8O5
Molecular Weight:
734.82
MDL Number:
MOL File:
2212020-29-4.mol

3-[(1S,2S)-1-[2-[[(4S)-3-(2,3-Dihydro-2-oxo-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-1H-indol-1-yl]-2-methylcyclopropyl]-1,2,4-oxadiazol-5(2H)-one Preparation Products And Raw materials

Raw materials

Preparation Products

3-[(1S,2S)-1-[2-[[(4S)-3-(2,3-Dihydro-2-oxo-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-1H-indol-1-yl]-2-methylcyclopropyl]-1,2,4-oxadiazol-5(2H)-one Suppliers

Global( 9)Suppliers
Supplier Tel Email Country ProdList Advantage
Shanghai Guangyang Jiali Biotechnology Co., Ltd
13407521611 46993711@qq.com China 176 58
Shanghai Subo Pharmaceutical Technology Co., Ltd. 021-54156369 16621315851 yhsuyiming@126.com China 277 58
Shanghai Guangyang Carrie Biotechnology Co., LTD 13127532723 1942593824@qq.com China 515 58
Cato Research Chemicals Inc. 020-81960175-877 18933936954 tianwen.zhan@cato-chem.com China 7259 58
ShenZhen Trendseen Biological Technology Co.,Ltd. 13417589054; trendseenbio@gmail.com China 9069 58
Suzhou Haiben Pharmaceutical Co., Ltd 19353112242 1816280386@qq.com China 8045 58
Jiangsu Aikon Biopharmaceutical R&D Co.,Ltd 025-58851090 17714375163 2881759498@qq.com China 13011 58
Guangzhou Viocon Pharmaceutical Technology Co., Ltd 13726739909 chenhuini@cti-cert.com China 500 58
Hubei Rhema Reference Materials Technology Co., Ltd. 15787875101 645977340@qq.com China 9970 58
3-[(1S,2S)-1-[2-[[(4S)-3-(2,3-Dihydro-2-oxo-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-1H-indol-1-yl]-2-methylcyclopropyl]-1,2,4-oxadiazol-5(2H)-one Orforglipron Impurity 60 2212020-29-4 C40H43FN8O5